- Home
- KYN vs CNTA Comparison
KYN vs CNTA Comparison
Compare KYN & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYN
- CNTA
- Stock Information
- Founded
- KYN 2004
- CNTA 2020
- Country
- KYN United States
- CNTA United Kingdom
- Employees
- KYN N/A
- CNTA N/A
- Industry
- KYN Finance/Investors Services
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- KYN Finance
- CNTA Health Care
- Exchange
- KYN Nasdaq
- CNTA Nasdaq
- Market Cap
- KYN 2.0B
- CNTA 1.6B
- IPO Year
- KYN N/A
- CNTA 2021
- Fundamental
- Price
- KYN $12.79
- CNTA $13.07
- Analyst Decision
- KYN
- CNTA Strong Buy
- Analyst Count
- KYN 0
- CNTA 10
- Target Price
- KYN N/A
- CNTA $28.78
- AVG Volume (30 Days)
- KYN 561.5K
- CNTA 1.2M
- Earning Date
- KYN 01-01-0001
- CNTA 08-12-2025
- Dividend Yield
- KYN 8.99%
- CNTA N/A
- EPS Growth
- KYN N/A
- CNTA N/A
- EPS
- KYN 0.71
- CNTA N/A
- Revenue
- KYN N/A
- CNTA $15,000,000.00
- Revenue This Year
- KYN N/A
- CNTA N/A
- Revenue Next Year
- KYN N/A
- CNTA N/A
- P/E Ratio
- KYN $13.79
- CNTA N/A
- Revenue Growth
- KYN N/A
- CNTA 118.88
- 52 Week Low
- KYN $7.84
- CNTA $8.46
- 52 Week High
- KYN $9.88
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- KYN 58.66
- CNTA 52.42
- Support Level
- KYN $12.18
- CNTA $12.74
- Resistance Level
- KYN $12.56
- CNTA $14.27
- Average True Range (ATR)
- KYN 0.17
- CNTA 0.68
- MACD
- KYN 0.01
- CNTA 0.11
- Stochastic Oscillator
- KYN 76.74
- CNTA 55.99
About KYN Kayne Anderson Energy Infrastructure Fund Inc.
Kayne Anderson Energy Infrastructure Fund, Inc is a non-diversified, closed-end fund. Its investment objective is to provide a high after-tax total return with an emphasis on making cash distributions to the stockholder. The Company invests in various sectors, which include midstream energy companies, renewable infrastructure companies, and utility companies. The company seeks to achieve its objectives by investing a majority of its total assets in the securities of Energy Infrastructure companies.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.